Know Your Investor: Janus Henderson Group Plc (April’25 Edition)

Shots: Welcome to the 2025 series of Know Your Investor, featuring top venture capital firms focused on healthcare. This edition highlights Janus Henderson Group Plc, a global investment firm managing approximately $378.7B in assets across Equities, Fixed Income, Multi-Asset, and Alternatives. In 2024, the firm invested $5.36B across six funding rounds, adding 39 healthcare and…

ByPrince GiriApril 3, 2025

News

Solid Biosciences’ SGT-212 Secures the US FDA’s Fast Track Designation for Treating Friedreich’s Ataxia

Shots:The US FDA has granted FTD to SGT-212 for treating Friedreich’s ataxia (FA) and previously approved its IND on Jan 07, 2025 The P-Ib study will assess safety & tolerability of contemporaneous systemic IV and bilateral IDN administration of SGT-212 in non-ambulatory and ambulatory FA patients for 5yrs., with dosing anticipated during H2’25…

BySenior EditorJanuary 22, 2025

Know Your Investor: Janus Henderson Group Plc (April’25 Edition)

Solid Biosciences’ SGT-212 Secures the US FDA’s Fast Track Designation for Treating Friedreich’s Ataxia

Contact US

OUR INFORMATION

FOLLW US

Know Your Investor: Janus Henderson Group Plc (April’25 Edition)

Solid Biosciences’ SGT-212 Secures the US FDA’s Fast Track Designation for Treating Friedreich’s Ataxia

FOLLW US

Sign Up to Our Newsletter